HCW Biologics Inc.
HCWB
$2.46
-$0.05-1.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 135.60K | 6.54M | 27.00K | 15.60K | 6.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 135.60K | 6.54M | 27.00K | 15.60K | 6.60K |
| Cost of Revenue | 229.50K | 11.10K | 21.60K | 12.50K | 5.20K |
| Gross Profit | -93.90K | 6.53M | 5.40K | 3.10K | 1.30K |
| SG&A Expenses | 1.90M | 1.87M | 3.66M | 1.92M | 2.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 198.10K | -- | -- | -- |
| Total Operating Expenses | 3.30M | 3.31M | 4.99M | 3.31M | 3.47M |
| Operating Income | -3.17M | 3.24M | -4.96M | -3.29M | -3.46M |
| Income Before Tax | -5.22M | 3.80M | 719.20K | -4.55M | -1.93M |
| Income Tax Expenses | -- | 330.20K | -- | -- | -- |
| Earnings from Continuing Operations | -5.22M | 3.47M | 719.20K | -4.55M | -1.93M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.22M | 3.47M | 719.20K | -4.55M | -1.93M |
| EBIT | -3.17M | 3.24M | -4.96M | -3.29M | -3.46M |
| EBITDA | -3.04M | 3.38M | -4.80M | -3.12M | -3.17M |
| EPS Basic | -11.58 | 2.19 | -6.15 | -12.09 | -40.72 |
| Normalized Basic EPS | -2.68 | 2.63 | -5.81 | -5.95 | -7.74 |
| EPS Diluted | -11.58 | 2.19 | -6.15 | -12.09 | -40.72 |
| Normalized Diluted EPS | -2.68 | 2.63 | -5.81 | -5.95 | -7.74 |
| Average Basic Shares Outstanding | 1.33M | 904.30K | 564.00K | 376.70K | 296.70K |
| Average Diluted Shares Outstanding | 1.33M | 904.30K | 564.00K | 376.70K | 296.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |